Stifel Financial’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Stifel Financial’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-72,045	Closed	-$1.34M	–	3502
2022 Q1	$1.34M	Sell	72,045 -430	-0.6%	-$7.74K	﹤0.01%	1905
2021 Q4	$1.55M	Hold	72,475	–	–	﹤0.01%	1812
2021 Q3	$1.34M	Hold	72,475	–	–	﹤0.01%	1862
2021 Q2	$1.55M	Sell	72,475 -151	-0.2%	-$3.07K	﹤0.01%	1786
2021 Q1	$1.4M	Buy	+72,626	New	+$1.28M	﹤0.01%	1762

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Stifel Financial's OCDX Position: Q2 2022 in Review

Stifel Financial sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 72,045 shares — an estimated $1.34M sold.

Stifel Financial first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $1.55M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Stifel Financial reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Stifel Financial sold 72,045 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.34M.
Stifel Financial first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Stifel Financial's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.55M in Q2 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Stifel Financial's 13F filing for Q2 2022, filed 15 Aug 2022.